Funded Tech Companies

ParcelBio

ParcelBio, operating out of San Francisco, received equity investments through General Catalyst, Metaplanet and private investors.

Company Overview

Contact Information

Company Background Information

Overview

ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm� platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/7/2026

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

David Weinberg

        

Chief Scientific Officer

Chris Carlson

        

Company Investors

• General Catalyst
• Metaplanet
• ZAKA VC
• Y Combinator
• Breyer Capital

Browse more funded tech companies:

Parcel.so | parcelLab

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary